DEXCOM INC will appoint two independent directors and restructure a key board committee following an agreement with activist investor Elliott Investment Management. Shares rose 6% in after-hours trading. The board currently lacks medtech and operations expertise, an area the medical device maker is addressing as it positions for future growth.
Dexcom to Add Board Directors in Elliott Agreement
Dexcom will add two directors and revamp its board committee in a deal with Elliott. The medical device maker aims to boost margins and operational expertise.
Xurve View
Insights:
Xurve View










